1 completed, 1 recruiting, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
Follow INNA-051: new trials by email Literature Review of INNA-051 trials Research Report on INNA-051
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age INNA-051, Placebo - Viral Respiratory Infection, Viral Respiratory Illnesses | Phase 2 | Recruiting | ENA Respiratory Pty Ltd | 1100 | 2025-12-04 | 2026-10-16 |
| Intranasal INNA-051 for Prevention of COVID-19 in Adults INNA-051, Placebo - COVID-19 Pandemic | Phase 2 | Withdrawn | ENA Respiratory Pty Ltd | 2022-03-01 | 2022-04-14 | |
| INNA-051 Influenza Challenge Study INNA-051, Placebo - Influenza Prophylaxis | Phase 2 | Completed | ENA Respiratory Pty Ltd | 123 | 2022-02-28 | 2023-01-18 |
COVID-19 (1)
United Kingdom (1) · United States (1)